Forum

South African Menopause Society revised consensus position statement on menopausal hormone therapy, 2014

Franco Guidozzi, A Alperstein, J S Bagratee, P Dalmeyer, M Davey, T J de Villiers, S Hirschowitz, T Kopenhager, S P Moodley, P Roos, A Shaw, O Shimange, T Smith, C Thomas, J Titus, Z van der Spuy, J van Waart

Abstract


The South African Menopause Society (SAMS) consensus position statement on menopausal hormone therapy (HT) 2014 is a revision of the SAMS Council consensus statement on menopausal HT published in the SAMJ in May 2007. Information presented in the previous statement has been re-evaluated and new evidence has been incorporated. While the recommendations pertaining to HT remain similar to those in the previous statement, the 2014 revision includes a wider range of clinical benefits for HT, the inclusion of non-hormonal alternatives such as selective serotonin reuptake inhibitors and serotonin noradrenaline reuptake inhibitors for the management of vasomotor symptoms, and an appraisal of bioidentical hormones and complementary medicines used for treatment of menopausal symptoms. New preparations that are likely to be more commonly used in the future are also mentioned. The revised statement emphasises that commencing HT during the ‘therapeutic window of opportunity’ maximises the benefit-to-risk profile of therapy in symptomatic menopausal women.


Authors' affiliations

Franco Guidozzi, President, South African Menopause Society; Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

A Alperstein, Private practice, Kingsbury House, Claremont, Cape Town, South Africa

J S Bagratee, Department of Obstetrics and Gynaecology, Nelson Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

P Dalmeyer, Part-time lecturer, University of Cape Town; Obstetrician/gynaecologist/reproductive medicine specialist, Cape Town, South Africa

M Davey, Private obstetrician/gynaecologist, Westville Clinic, KwaZulu-Natal, South Africa

T J de Villiers, Private practice, Cape Town, South Africa

S Hirschowitz, Private practice, Park Lane, Johannesburg, South Africa

T Kopenhager, Private practice, Park Lane, Johannesburg, South Africa

S P Moodley, Executive Committee Member, South African Menopause Society; Ethekweni, Umhlanga and Victoria hospitals, KwaZulu-Natal, South Africa

P Roos, Private practice, Vincent Pallotti Hospital, Cape Town, South Africa

A Shaw, Private practice, Knysna Life Hospital, Eastern Cape, South Africa

O Shimange, Private practice, Mediclinic, Medforum Hospital, Pretoria, South Africa

T Smith, Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

C Thomas, Secretary, South African Menopause Society; Life Kingsbury Hospital, Cape Town, South Africa

J Titus, Department of Obstetrics and Gynaecology, Nelson Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

Z van der Spuy, Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of Cape Town, South Africa

J van Waart, Private practice, Wijnland Fertility Unit, Stellenbosch, Western Cape, South Africa

Full Text

PDF (1182KB)

Keywords

Menopause therapy

Cite this article

South African Medical Journal 2014;104(8):537-543. DOI:10.7196/SAMJ.8423

Article History

Date submitted: 2014-05-06
Date published: 2014-06-19

Article Views

Abstract views: 4602
Full text views: 3395

Comments on this article

*Read our policy for posting comments here